ArticleOncoimmunology2015

Axitinib increases the infiltration of immune cells and reduces the suppressive capacity of monocytic MDSCs in an intracranial mouse melanoma model.

Stephanie Du Four et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.